Revolution Medicines (RVMD) Shareholder's Equity (2018 - 2026)

Revolution Medicines (RVMD) Shareholder's Equity (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 7.14 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 595,226.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - 502.95 Mn
10 Revolution Medicines 32.33 Bn 32.33 Bn - 1.50 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.50 Bn
Dec 31, 2025 1.63 Bn
Sep 30, 2025 1.60 Bn
Jun 30, 2025 1.87 Bn
Mar 31, 2025 2.08 Bn
Dec 31, 2024 2.27 Bn
Sep 30, 2024 1.57 Bn
Jun 30, 2024 1.62 Bn
Mar 31, 2024 1.73 Bn
Dec 31, 2023 1.83 Bn
Sep 30, 2023 837.46 Mn
Jun 30, 2023 930.84 Mn
Mar 31, 2023 952.22 Mn
Dec 31, 2022 685.19 Mn
Sep 30, 2022 681.42 Mn
Jun 30, 2022 498.84 Mn
Mar 31, 2022 550.99 Mn
Dec 31, 2021 602.57 Mn
Sep 30, 2021 638.20 Mn
Jun 30, 2021 685.01 Mn